Table 1.
Results of Serological Investigations in Humans
| IFA Cut-off for chronic form of disease, IgG phase I antibody titer ≥1:1024 Cut-off for acute form, IgG or IgM II titer ≥1:32 | ELISAa | CFT Cut-off titer ≥1:32 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of seropositive for phase II | |||||||||||||
| Examined group localities-voivodship | Number of examined (gender)/average age±standard deviation | Total number of seropositive | Number of seropositive for IgG phase II | Number of seropositive for IgG phase Ib | Ttotal number of seropositive | IgM | IgG | Seropositive for both IgM and IgG | totally | Number of seropositive for IgG phase I | Number of seropositive (phase I and II) | Seropositive phase I | Seropositive phase II |
| Dębno Małopolskie |
26 (18 women, 8 men) 44.1±15.25 |
11 (42.31%) | 3 (11.53%) | 8 (30.76%) | 13 (50%) | 1 (3.84%) | 7 (26.92%) | 3 (11.54%) | 11 (42.31%) | 2 (7.69%) | 6 (23.08%) | 0 | 2 (7.69%) |
| Tarnogród Lubelskie |
29 (20 women, 9 men) 48.4±8.24 |
2 (6.90%) | 2 (6.90%) | 0 | 13 (44.83%) | 4 (13.79%) | 5 (17.24%) | 1 (3.45%) | 10 (34.48%) | 3 (10.34%) | 2 (6.90%) | 0 | 4 (13.79%) |
| Krosno Podkarpackie |
6 (6 men) 51.33±4.22 |
1 (16.67%) | 0 | 1 (16.67%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gliwice Śląskie |
11 (9 women, 2 men) 45.36±9.18 |
2 (18.18%) | 1 (9.09%) | 1 (9.09%) | 6 (54.54%) | 0 | 2 (18.18%) | 0 | 2 (18.18%) | 4 (36.36%) | 1 (9.09%) | 0 | 0 |
| Chodzież Wielkopolskie |
71 (25 women, 46 men) 46.7±3.48 |
30 (42.25%) | 6 (8.45%) | 24 (33.80%) | 25 (35.21%) | 4 (5.63%) | 9 (12,67%) | 3 (4.22%) | 16 (22.53%) | 9 (12.68%) | 8 (11.27%) | 0 | 14 (19.72%) |
| Ciechanów Mazowieckie |
8 (4 women, 4 men) 51.3±5.43 |
1 (12.50%) | 1 (12.50%) | 0 | 2 (25%) | 1 (12.50%) | 1 (12.50%) | 0 | 2 (25%) | 0 | 1 (12.50%) | 0 | 3 (37.50%) |
| Total | 151 (76 women, 75 men) 47.11±8.41 |
46 (31.12%) | 13 (8.60%) | 34 (22.52%) | 59 (39.07%) | 10 (6.62%) | 24 (15.89%) | 7 (4.63%) | 41 (27.15%) | 18 (11.92%) | 18 (11.92%) | 0 | 23 (15.23%) |
a
Presence of antibodies IgM and IgG in phase II=possible acute phase of Q fever.
b
Presence of antibodies IgG in phase I possible chronic infection (the reference methods for confirmation chronic form of Q fever is IFA).
IFA, indirect fluorescent antibody; IgG, immunoglobulin G; ELISA, enzyme-linked immunosorbent assay; CFT, complement fixation test.